Skip to main content

Table 2 Viability (A) and mortality (B) of the A. aegypti individual treatment with burchellin

From: Burchellin: study of bioactivity against Aedes aegypti

A L3-L4 L4 - Pupae Pupae -adult L3-Adult
X ± SD % X ± SD % X ± SD % X ± SD %
Control 10.0 ± 0 100 10.0 ± 0a 100 10.0 ± 0a 100 10.0 ± 0a 100
Control 2 10.0 ± 0 100 10.0 ± 0ab 100 10.0 ± 0ab 100 10.0 ± 0ab 100
0.001 μg/mL 10.0 ± 0 100 10.0 ± 0ab 100 10.0 ± 0ab 100 10.0 ± 0ab 100
0.01 μg/mL 10.0 ± 0 100 10.0 ± 0ab 77 7.5 ± 0.6d*** 100 7.5 ± 0.6d*** 77
0.1 μg/mL 10.0 ± 0 100 10.0 ± 0ab 73 7.3 ± 0.6d*** 100 7.3 ± 0.6d*** 73
0.3 μg/mL 10.0 ± 0 100 10.0 ± 0ab 67 6.6 ± 0.6d*** 100 6.6 ± 0.6d*** 67
0.5 μg/mL 10.0 ± 0 100 10.0 ± 0ab 30 3.0 ± 1.0 c*** 100 3.0 ± 1.0c*** 30
B Larvae   Pupae  
X ± SD VI % X ± SD VI %
Control 0 0 0 0 0 0
Control 2 0 0 0 0 0 0
0.001 μg/mL 0 0 0 0 0 0
0.01 μg/mL 2.4 ± 0.6c** 2-2 23 0 0 0
0.1 μg/mL 2.6 ± 0.6c** 2-2 27 0 0 0
0.3 μg/mL 3.3 ± 0.6c*** 2-3 33 0 0 0
0.5 μg/mL 7.0 ± 1.0d*** 2-3 70 0 0 0
  1. Burchellin treatment on A. aegypti at 0.001 – 0.5 μg/mL concentration. Values are mean ± standard deviation (X ± SD), average of three replicates of 10 larvae L3 per each group. Values followed by the same letter did not significantly different from each other, P > 0.05 when the Tukey test was used. Significance levels are represented as ***P < 0.001 and *P < 0.05 vs. Control 2 = Acetone control. NO = not observed.
\